First Page | Document Content | |
---|---|---|
Health Pharmaceuticals policy Clinical research Federal Department of Home Affairs Swissmedic Pharmaceutical industry Healthcare quality Marketing authorization Statistical process control Pharmacovigilance IB Bioequivalence | ZL300_00_001e_WL Guidance document Variations and extensions HMV4Add to Reading ListSource URL: www.swissmedic.chDownload Document from Source WebsiteFile Size: 434,97 KBShare Document on Facebook |
PDF DocumentDocID: 1xLRP - View Document | |
PDF DocumentDocID: 1xJUP - View Document | |
DOC DocumentDocID: 1xHuu - View Document | |
DOC DocumentDocID: 1xAxm - View Document | |
PDF DocumentDocID: 1xrVP - View Document |